Literature DB >> 9407378

Detection of herpes simplex virus type-specific antibodies by an enzyme-linked immunosorbent assay based on glycoprotein G.

M Hashido1, F K Lee, S Inouye, T Kawana.   

Abstract

In order to develop a simple and quantitative method to detect herpes simplex virus (HSV) type-specific antibodies, the usefulness of an enzyme-linked immunosorbent assay (ELISA) using HSV glycoprotein G (gG) captured on a plate by monoclonal antibodies as antigen was studied. The gG1- and gG2-specific IgG antibody activities were measured by the ELISA for 54 sera which had been collected from culture-proven genital herpes patients and pre-characterized by an immunodot assay using purified gG antigens. Thirty control sera without antibodies against the HSV whole antigens were also included. In comparison with the immunodot assay as standard, the sensitivities of the ELISA were 88.9% (32/36) for HSV-1 antibody and 89.2% (33/37) for HSV-2 antibody and the specificities were both 100%. Sera taken within a few months after primary infection tended to give false negative results. The HSV type-specific ELISA based on easy-to-prepare gG antigens might be useful to help improve the serological assessment of HSV infections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9407378     DOI: 10.1002/(sici)1096-9071(199712)53:4<319::aid-jmv2>3.0.co;2-a

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  13 in total

1.  Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2-specific IgG antibodies.

Authors:  H E Prince; C E Ernst; W R Hogrefe
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

Review 2.  Sorting out the new HSV type specific antibody tests.

Authors:  R L Ashley
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

3.  Performance and use of a ribonucleotide reductase herpes simplex virus type-specific serological assay.

Authors:  S Q Wales; C C Smith; M Wachsman; G Calton; L Aurelian
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

4.  Conservation of type-specific B-cell epitopes of glycoprotein G in clinical herpes simplex virus type 2 isolates.

Authors:  J A Liljeqvist; B Svennerholm; T Bergström
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

5.  Variability of the glycoprotein G gene in clinical isolates of herpes simplex virus type 1.

Authors:  E Rekabdar; P Tunbäck; J A Liljeqvist; T Bergström
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

6.  Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection.

Authors:  R L Ashley; M Eagleton; N Pfeiffer
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

Review 7.  Genital herpes: review of the epidemic and potential use of type-specific serology.

Authors:  R L Ashley; A Wald
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

8.  Use of baculovirus-expressed glycoprotein H in an enzyme-linked immunosorbent assay developed to assess exposure to chelonid fibropapillomatosis-associated herpesvirus and its relationship to the prevalence of fibropapillomatosis in sea turtles.

Authors:  Lawrence H Herbst; Shefali Lemaire; Ada R Ene; David J Heslin; Llewellyn M Ehrhart; Dean A Bagley; Paul A Klein; Jack Lenz
Journal:  Clin Vaccine Immunol       Date:  2008-03-26

9.  Performance of the focus and Kalon enzyme-linked immunosorbent assays for antibodies to herpes simplex virus type 2 glycoprotein G in culture-documented cases of genital herpes.

Authors:  Rhoda Ashley Morrow; David Friedrich; Elizabeth Krantz
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

10.  Use of a fragment of glycoprotein G-2 produced in the baculovirus expression system for detecting herpes simplex virus type 2-specific antibodies.

Authors:  Minako Ikoma; Jan-Ake Liljeqvist; Jan Groen; Koen L Glazenburg; T Hauw The; Sytske Welling-Wester
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.